Call : 08045479148
Afatinib belongs to a class of drugs called kinase inhibitors. It is an EGFR tyrosine kinase inhibitor that works by irreversibly blocking EGFR.
Afatinib helps to stop or slow the spread of cancer and may help people with EGFR-positive NSCLC live longer. It was approved by the US Food and Drug Administration in 2013.
AKSHAR PHARMA
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |